A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Recruiting now · Phase 3
Conditions studied: Biliary Tract Cancer
In brief
The purpose of this study is to measure the efficacy and safety of rilvegostomig with gemcitabine plus cisplatin vs. durvalumab with gemcitabine plus cisplatin as first line treatment for patients with advanced BTC.
Key facts
- Study ID
- NCT07221253
- Run by
- AstraZeneca
- People needed
- 1100
- Starts
- 2025-12-04
- Expected to finish
- 2029-07-31
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Edegem, Belgium (enrolling)
- Research Site — Barretos, Brazil (enrolling)
- Research Site — Sioux Falls, South Dakota, United States (enrolling)
- Research Site — Anderlecht, Belgium (enrolling)
- Research Site — Roeselare, Belgium (enrolling)
- Research Site — Tucson, Arizona, United States (enrolling)
- Research Site — Providence, Rhode Island, United States (enrolling)
- Research Site — Pierre, South Dakota, United States (enrolling)
- Research Site — Darlinghurst, Australia (enrolling)
- Research Site — Murdoch, Australia (enrolling)
- Research Site — Leuven, Belgium (enrolling)
- Research Site — Gainesville, Florida, United States (enrolling)
- Research Site — Jacksonville, Florida, United States (enrolling)
- Research Site — Marietta, Georgia, United States (enrolling)
- Research Site — Aurora, Colorado, United States (enrolling)
- Research Site — Phoenix, Arizona, United States (enrolling)
- Research Site — Duarte, California, United States (enrolling)
- Research Site — Louisville, Kentucky, United States (enrolling)
- Research Site — Baltimore, Maryland, United States (enrolling)
- Research Site — New Haven, Connecticut, United States (enrolling)
- Research Site — Orange, California, United States (enrolling)
- Research Site — Rochester, Minnesota, United States (enrolling)
- Research Site — Palo Alto, California, United States (enrolling)
- Research Site — Santa Fe, New Mexico, United States (enrolling)
- Research Site — Natal, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.